Skip to main content
David Nanus, MD, Oncology, New York, NY, New York-Presbyterian Hospital

DavidMNanusMD

Oncology • New York, NY

Mark W. Pasmantier Professor of Hematology and Medical Oncology in Medicine Director of New York Presbyterian Hospital - Weill Cornell Medicine Healthcare Systems Cancer Program Associate Director for Clinical Services Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine

Request Appointment

Overview of Dr. Nanus

I am the Director of New York Presbyterian Hospital - Weill Cornell Medicine Healthcare Systems Cancer Program and the Associate Director for Clinical Services in the Meyer Cancer Center at Weill Cornell Medicine. I was Chief of the Division of Hematology and Medical Oncology at Weill Cornell Medical College – New York Presbyterian Hospital for a5 years from 2004-2019. I am also the Mark W. Pasmantier Professor of Hematology and Medical Oncology in Medicine and Professor of Medicine and Urology. I completed my clinical training in Medicine at Albert Einstein College of Medicine followed by a fellowship in Medical Oncology at Memorial Sloan Kettering Cancer Center, and research training at the Sloan Kettering Institute. I joined the faculty at Memorial Sloan Kettering Cancer Center in 1989 as a physician scientist and was recruited to the full-time faculty of Weill Cornell Medical College in 1998. My clinical focus is the treatment and care of patients with genitourinary (GU) cancers, and I am actively involved in clinical, translational and basic research in GU malignancies, serving as principle or co-investigator on a variety of grants and clinical research trials that incorporate novel targeted therapies for patients, working closely with physicians and scientists.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1985 - 1989
  • Jacobi Medical Center/Albert Einstein College of Medicine
    Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1983 - 1985
  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsInternship, Internal Medicine, 1982 - 1983
  • Chicago Medical School at Rosalind Franklin University of Medicine and Science
    Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1982
  • University of Illinois at Urbana-Champaign
    University of Illinois at Urbana-ChampaignB.S., 1974 - 1978

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1983 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Member American Association of Physicians, 2005
  • Top Doctors for Cancer Newsweek Magazine, 2015
  • Top Ranked U.S. Executive National Council of American Executives, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Kidney cancer: novel targets in altered tumour metabolism  
    Minton DR and Nanus DM, Nature Rev Urol, 1/1/2015
  • CANCER Cancer therapies that are gone with the Wnt  
    Nanus DM and Giannakakou P, Science, 1/1/2015
  • The tale of two hypoxia-inducible factors in renal cell carcinoma  
    Nanus DM and Gudas LJ, Eur Urol, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Nuclear Medicine Therapy: Principles and Clinical Applications 
    Chapter: Radioimmunotherapy of prostate carcinoma. 
    Goldsmith SJ, Tagawa ST, Vallabhajosula S, Nikolopoulou A, Lipai I, Nanus DM, Bander NHEditors: Aktolun C and Goldsmith SJ.Springer Science+Business Media2013
  • ASCO-SEP Medical Oncology Self- Evaluation Program Version III 
    Chapter: Genitourinary Cancers 
    Nanus DM and Milowsky MIEditors: Moore A.American Society of Clinical Oncology2013
  • Targeted Therapies for Renal Cell Carcinoma 
    Chapter: Chemotherapy in metastatic RCC: A targeted approach in non-clear-cell and sarcomatoid/rapidly progressive RCC 
    Diamond E, Akhtar NH, Tagawa ST, Nanus DMEditors: Bukowski R.Future Science Group2012
  • Join now to see all

Lectures

  • Taxanes: Novel Combinations and Clinical States 
    Chicago, IL - 1/29/2015
  • Circulating Tumor Cells in the Microenvironment 
    Lawrence Livermore National Laboratory, CA - 1/27/2015
  • Advances and clinical trial opportunities in immunotherapy for GU cancers. 
    Las Vegas, NV - 1/13/2015
  • Join now to see all

Other

  • Beyond the Abstract - Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer. 
    Beltran H, Nanus DM, Tagawa ST, UroToday.com
    1/30/2010
  • Recent advances in management of renal cancer. 
    Shah JH, Nanus DM, f1000 Medicine Reports
    1/1/2009

Press Mentions

  • How to Find Support When You Have Metastatic Kidney Cancer
    How to Find Support When You Have Metastatic Kidney CancerApril 25th, 2023
  • Department of Defense Awards Weill Cornell Medicine New Grant for Kidney Cancer Research
    Department of Defense Awards Weill Cornell Medicine New Grant for Kidney Cancer ResearchSeptember 1st, 2022
  • Cancers Leading Cause of Premature Death in Brooklyn: NY-Presbyterian Physicians
    Cancers Leading Cause of Premature Death in Brooklyn: NY-Presbyterian PhysiciansAugust 7th, 2019
  • Join now to see all

Grant Support

  • Phase II Trial Of 177lu-J591 In Metastatic, Androgen-Independent Prostate CancerNational Center For Research Resources2007
  • Phase I Trial Of ATRA-IV &Depakote In PTS W/Advanced Solid Tumor MalignanciesNational Center For Research Resources2005–2006
  • Modulation Of Retinoic Acid Action In Renal CancerNational Cancer Institute2001–2005
  • Neutral Endopeptidase Inactivation In Advanced ProstateNational Cancer Institute1998–2005
  • Phase I 111-Indium Radiolabeled MAB Huj591/ Metastatic Solid TumorsNational Center For Research Resources2004
  • Chemoprevention Of Prostate Cancer With FinasterideNational Center For Research Resources2004
  • Anti Tumor Therapies For Genioturinary MalignanciesNational Cancer Institute2000–2004
  • Alpha Interferon Resistance In Renal CancerNational Cancer Institute1994–1996
  • Analysis Of Alpha-Interferon Resistance In Renal CancerNational Cancer Institute1992–1993

Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Choice
    First Health PPO
    GHI PPO
    Great West PPO
    Health Net Oregon PPO
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    Medical Mutual of Ohio SuperMed Plus
    Medical Mutual of Ohio SuperMed POS
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    Premera BCBS Heritage & Heritage Plus 1
    Providence Health System Personal Option
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. David Nanus, Dr. David Nanus, MD, Dr. D Nanus, Dr. David M Nanus